Hsian-Rong Tseng,
Professor, Crump Institute for Molecular Imaging, California NanoSystems Institute,
University of California-Los Angeles
Dr. Tseng is professor in the Department of Molecular & Medical Pharmacology at UCLA. He also holds memberships of the California NanoSystems Institute, Crump Institute for Molecular Imaging and Institute for Molecular Medicine on the UCLA campus. Since he joined UCLA Pharmacology in 2003, Dr. Tseng’s group at UCLA has developed a series of nanotechnology- and microfluidics-enabled in vitro molecular diagnostic (IVMD) technologies. In collaboration with his physician colleagues, the goal of their joint team is to translate these new IVMD technologies from research bench to clinical practice.
NanoVelcro Rare-Cell Assays for Detection and Characterization of Circulating Tumor Cells
Monday, 5 November 2018 at 14:00
Add to Calendar ▼2018-11-05 14:00:002018-11-05 15:00:00Europe/LondonNanoVelcro Rare-Cell Assays for Detection and Characterization of Circulating Tumor CellsAsia Diagnostics Summit 2018 in Taipei, TaiwanTaipei, TaiwanSELECTBIOenquiries@selectbiosciences.com
Circulating tumor cells (CTCs) are cancer cells shredded from either a primary tumor or a metastatic site and circulate in the blood as the potential cellular origin of metastasis. By detecting and analyzing CTCs, we will be able to noninvasively monitor disease progression in individual cancer patients and obtain insightful information for assessing disease status, thus realizing the concept of “tumor liquid biopsy”. Over the past decade, our research team at UCLA pioneered a unique concept of “NanoVelcro” cell-affinity substrates, in which CTC capture agent-coated nanostructured substrates were utilized to immobilize CTCs with remarkable efficiency. Five generations of NanoVelcro CTC assays have been developed over the past decade for a variety of clinical utilities, including CTC enumeration for prognosis and staging, single-CTC mutational analysis for tracking tumor origin, and CTC-based molecular analysis for treatment monitoring. In this presentation, I will summarize the development of the new generations of NanoVelcro CTC assays and the clinical applications of these new diagnostic devices.
Add to Calendar ▼2018-11-05 00:00:002018-11-06 00:00:00Europe/LondonAsia Diagnostics Summit 2018Asia Diagnostics Summit 2018 in Taipei, TaiwanTaipei, TaiwanSELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2018-11-05 14:00:002018-11-05 15:00:00Europe/LondonNanoVelcro Rare-Cell Assays for Detection and Characterization of Circulating Tumor CellsAsia Diagnostics Summit 2018 in Taipei, TaiwanTaipei, TaiwanSELECTBIOenquiries@selectbiosciences.com
